Dr Elizabeth Burton, | |
3941 Commerce Ave, Willow Grove, PA 19090-1104 | |
(215) 481-4000 | |
Not Available |
Full Name | Dr Elizabeth Burton |
---|---|
Gender | Female |
Speciality | Gynecological Oncology |
Experience | 19 Years |
Location | 3941 Commerce Ave, Willow Grove, Pennsylvania |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1124352315 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Thomas Jefferson University Hospital | Philadelphia, PA | Hospital |
Abington Memorial Hospital | Abington, PA | Hospital |
Albert Einstein Medical Center | Philadelphia, PA | Hospital |
Doylestown Hospital | Doylestown, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Abington Memorial Hospital | 3274437736 | 528 |
Einstein Practice Plan Inc | 2769395896 | 591 |
News Archive
The "Radiation and the Modern Management of Lymphoma" issue (May 1, 2015) of the International Journal of Radiation Oncology • Biology • Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology, is focused on the integral role of radiation therapy in current lymphoma treatment.
Human Genome Sciences, Inc. and GlaxoSmithKline PLC today announced the presentation of additional results from BLISS-52, one of two pivotal Phase 3 trials of BENLYSTA (belimumab) in seropositive patients with systemic lupus erythematosus. The additional data will be presented in Rome at the 2010 Congress of the European League against Rheumatism on Saturday, June 19.
Nautilus, Inc. reported today its unaudited operating results for the first quarter ended March 31, 2012.
DermaGen AB - part of the Karolinska Development dermatology and wound healing company "Pergamum" - announced that Dermagen AB has received promising results from a clinical Phase I/IIa study. DermaGen AB is developing a novel antimicrobial peptide (AMP) treatment for atopic dermatitis. Atopic dermatitis is a chronic inflammatory skin disease where dry skin and the skin's weakened barrier function make patients susceptible to colonization by microorganisms, a triggering or exacerbating factor of the disease.
AIDS Healthcare Foundation (AHF), the US' largest non-profit HIV/AIDS healthcare provider, which provides medical care and/or services to more than 100,000 individuals in 21 countries worldwide, is honored to announce the September 24th grand opening of AHF's first AIDS treatment center in Washington, DC, where the HIV rate is now reported to be 3%—higher than the rate in Lagos, Nigeria.
› Verified 2 days ago
Entity Name | Einstein Practice Plan Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1760434468 PECOS PAC ID: 2769395896 Enrollment ID: O20040219000728 |
News Archive
The "Radiation and the Modern Management of Lymphoma" issue (May 1, 2015) of the International Journal of Radiation Oncology • Biology • Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology, is focused on the integral role of radiation therapy in current lymphoma treatment.
Human Genome Sciences, Inc. and GlaxoSmithKline PLC today announced the presentation of additional results from BLISS-52, one of two pivotal Phase 3 trials of BENLYSTA (belimumab) in seropositive patients with systemic lupus erythematosus. The additional data will be presented in Rome at the 2010 Congress of the European League against Rheumatism on Saturday, June 19.
Nautilus, Inc. reported today its unaudited operating results for the first quarter ended March 31, 2012.
DermaGen AB - part of the Karolinska Development dermatology and wound healing company "Pergamum" - announced that Dermagen AB has received promising results from a clinical Phase I/IIa study. DermaGen AB is developing a novel antimicrobial peptide (AMP) treatment for atopic dermatitis. Atopic dermatitis is a chronic inflammatory skin disease where dry skin and the skin's weakened barrier function make patients susceptible to colonization by microorganisms, a triggering or exacerbating factor of the disease.
AIDS Healthcare Foundation (AHF), the US' largest non-profit HIV/AIDS healthcare provider, which provides medical care and/or services to more than 100,000 individuals in 21 countries worldwide, is honored to announce the September 24th grand opening of AHF's first AIDS treatment center in Washington, DC, where the HIV rate is now reported to be 3%—higher than the rate in Lagos, Nigeria.
› Verified 2 days ago
Entity Name | Aria Health Physician Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1750949806 PECOS PAC ID: 3577467018 Enrollment ID: O20040224000045 |
News Archive
The "Radiation and the Modern Management of Lymphoma" issue (May 1, 2015) of the International Journal of Radiation Oncology • Biology • Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology, is focused on the integral role of radiation therapy in current lymphoma treatment.
Human Genome Sciences, Inc. and GlaxoSmithKline PLC today announced the presentation of additional results from BLISS-52, one of two pivotal Phase 3 trials of BENLYSTA (belimumab) in seropositive patients with systemic lupus erythematosus. The additional data will be presented in Rome at the 2010 Congress of the European League against Rheumatism on Saturday, June 19.
Nautilus, Inc. reported today its unaudited operating results for the first quarter ended March 31, 2012.
DermaGen AB - part of the Karolinska Development dermatology and wound healing company "Pergamum" - announced that Dermagen AB has received promising results from a clinical Phase I/IIa study. DermaGen AB is developing a novel antimicrobial peptide (AMP) treatment for atopic dermatitis. Atopic dermatitis is a chronic inflammatory skin disease where dry skin and the skin's weakened barrier function make patients susceptible to colonization by microorganisms, a triggering or exacerbating factor of the disease.
AIDS Healthcare Foundation (AHF), the US' largest non-profit HIV/AIDS healthcare provider, which provides medical care and/or services to more than 100,000 individuals in 21 countries worldwide, is honored to announce the September 24th grand opening of AHF's first AIDS treatment center in Washington, DC, where the HIV rate is now reported to be 3%—higher than the rate in Lagos, Nigeria.
› Verified 2 days ago
Entity Name | Abington Memorial Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1750306726 PECOS PAC ID: 3274437736 Enrollment ID: O20060524000014 |
News Archive
The "Radiation and the Modern Management of Lymphoma" issue (May 1, 2015) of the International Journal of Radiation Oncology • Biology • Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology, is focused on the integral role of radiation therapy in current lymphoma treatment.
Human Genome Sciences, Inc. and GlaxoSmithKline PLC today announced the presentation of additional results from BLISS-52, one of two pivotal Phase 3 trials of BENLYSTA (belimumab) in seropositive patients with systemic lupus erythematosus. The additional data will be presented in Rome at the 2010 Congress of the European League against Rheumatism on Saturday, June 19.
Nautilus, Inc. reported today its unaudited operating results for the first quarter ended March 31, 2012.
DermaGen AB - part of the Karolinska Development dermatology and wound healing company "Pergamum" - announced that Dermagen AB has received promising results from a clinical Phase I/IIa study. DermaGen AB is developing a novel antimicrobial peptide (AMP) treatment for atopic dermatitis. Atopic dermatitis is a chronic inflammatory skin disease where dry skin and the skin's weakened barrier function make patients susceptible to colonization by microorganisms, a triggering or exacerbating factor of the disease.
AIDS Healthcare Foundation (AHF), the US' largest non-profit HIV/AIDS healthcare provider, which provides medical care and/or services to more than 100,000 individuals in 21 countries worldwide, is honored to announce the September 24th grand opening of AHF's first AIDS treatment center in Washington, DC, where the HIV rate is now reported to be 3%—higher than the rate in Lagos, Nigeria.
› Verified 2 days ago
Entity Name | Abington Memorial Hospital |
---|---|
Entity Type | Part B Supplier - Hospital Department(s) |
Entity Identifiers | NPI Number: 1316189855 PECOS PAC ID: 3274437736 Enrollment ID: O20091218000204 |
News Archive
The "Radiation and the Modern Management of Lymphoma" issue (May 1, 2015) of the International Journal of Radiation Oncology • Biology • Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology, is focused on the integral role of radiation therapy in current lymphoma treatment.
Human Genome Sciences, Inc. and GlaxoSmithKline PLC today announced the presentation of additional results from BLISS-52, one of two pivotal Phase 3 trials of BENLYSTA (belimumab) in seropositive patients with systemic lupus erythematosus. The additional data will be presented in Rome at the 2010 Congress of the European League against Rheumatism on Saturday, June 19.
Nautilus, Inc. reported today its unaudited operating results for the first quarter ended March 31, 2012.
DermaGen AB - part of the Karolinska Development dermatology and wound healing company "Pergamum" - announced that Dermagen AB has received promising results from a clinical Phase I/IIa study. DermaGen AB is developing a novel antimicrobial peptide (AMP) treatment for atopic dermatitis. Atopic dermatitis is a chronic inflammatory skin disease where dry skin and the skin's weakened barrier function make patients susceptible to colonization by microorganisms, a triggering or exacerbating factor of the disease.
AIDS Healthcare Foundation (AHF), the US' largest non-profit HIV/AIDS healthcare provider, which provides medical care and/or services to more than 100,000 individuals in 21 countries worldwide, is honored to announce the September 24th grand opening of AHF's first AIDS treatment center in Washington, DC, where the HIV rate is now reported to be 3%—higher than the rate in Lagos, Nigeria.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Elizabeth Burton, 3941 Commerce Ave, Willow Grove, PA 19090-1104 Ph: (215) 481-4000 | Dr Elizabeth Burton, 3941 Commerce Ave, Willow Grove, PA 19090-1104 Ph: (215) 481-4000 |
News Archive
The "Radiation and the Modern Management of Lymphoma" issue (May 1, 2015) of the International Journal of Radiation Oncology • Biology • Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology, is focused on the integral role of radiation therapy in current lymphoma treatment.
Human Genome Sciences, Inc. and GlaxoSmithKline PLC today announced the presentation of additional results from BLISS-52, one of two pivotal Phase 3 trials of BENLYSTA (belimumab) in seropositive patients with systemic lupus erythematosus. The additional data will be presented in Rome at the 2010 Congress of the European League against Rheumatism on Saturday, June 19.
Nautilus, Inc. reported today its unaudited operating results for the first quarter ended March 31, 2012.
DermaGen AB - part of the Karolinska Development dermatology and wound healing company "Pergamum" - announced that Dermagen AB has received promising results from a clinical Phase I/IIa study. DermaGen AB is developing a novel antimicrobial peptide (AMP) treatment for atopic dermatitis. Atopic dermatitis is a chronic inflammatory skin disease where dry skin and the skin's weakened barrier function make patients susceptible to colonization by microorganisms, a triggering or exacerbating factor of the disease.
AIDS Healthcare Foundation (AHF), the US' largest non-profit HIV/AIDS healthcare provider, which provides medical care and/or services to more than 100,000 individuals in 21 countries worldwide, is honored to announce the September 24th grand opening of AHF's first AIDS treatment center in Washington, DC, where the HIV rate is now reported to be 3%—higher than the rate in Lagos, Nigeria.
› Verified 2 days ago
Sherry L Blumenthal, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2701 Blair Mill Rd, Suite C, Willow Grove, PA 19090 Phone: 215-443-0660 Fax: 215-443-8422 | |
Frank Theodore Sandsorum Jr., MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2300 Computer Rd, Ste E25, Willow Grove, PA 19090 Phone: 215-659-8080 Fax: 215-659-0977 | |
Vahideh T Ameri, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 735 Fitzwatertown Rd, Suite 4, Willow Grove, PA 19090 Phone: 215-914-4400 Fax: 215-657-4887 | |
Patricia Ann Sullivan, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2701 Blair Mill Rd Ste C, Willow Grove, PA 19090 Phone: 215-443-0660 Fax: 215-443-8422 | |
Joseph James Murphy Iii, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2300 Computer Rd Ste E25, Willow Grove, PA 19090 Phone: 215-366-1160 Fax: 215-672-6853 | |
Jessica M. Klemens, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2701 Blair Mill Rd, Suite C, Willow Grove, PA 19090 Phone: 215-443-0660 Fax: 215-443-8422 |